IRONWOOD PHARMACEUTICALS INC - COM CL A (IRWD)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q3 2024
163M
Holdings value Q3 2024
$672M
Value change Q3 2024
-$58.2M
Grand Portfolio weight change Q3 2024
0%
Number of holders
217
Number of buys Q3 2024
101
Number of sells Q3 2024
-120
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 163M $672M -$58.2M $4.12 217
2024 Q2 171M $1.12B -$6.09M $6.52 226
2024 Q1 171M $1.49B +$26.6M $8.71 264
2023 Q4 165M $1.88B +$34.2M $11.44 248
2023 Q3 161M $1.55B -$57.8M $9.63 247
2023 Q2 166M $1.77B +$4.55M $10.64 249
2023 Q1 165M $1.74B -$25.4M $10.52 252
2022 Q4 168M $2.08B -$12M $12.39 246
2022 Q3 170M $1.76B -$67.5M $10.36 232
2022 Q2 175M $2.02B +$105M $11.53 229
2022 Q1 167M $2.09B -$62.7M $12.58 205
2021 Q4 172M $2B -$78.2M $11.66 209
2021 Q3 177M $2.32B +$38.2M $13.06 218
2021 Q2 175M $2.25B +$54.4M $12.87 202
2021 Q1 171M $1.91B -$10.3M $11.18 203
2020 Q4 172M $1.95B -$290K $11.39 192
2020 Q3 179M $1.61B -$60M $9.00 184
2020 Q2 178M $1.84B +$1.17M $10.32 198
2020 Q1 179M $1.8B +$4.16M $10.09 187
2019 Q4 177M $2.36B +$49.4M $13.31 194
2019 Q3 174M $1.49B +$101M $8.59 157
2019 Q2 161M $1.76B +$57.8M $10.94 150
2019 Q1 155M $2.09B +$91.1M $13.53 153
2018 Q4 150M $1.55B -$71.2M $10.36 143
2018 Q3 145M $2.67B -$61M $18.46 152
2018 Q2 149M $2.85B -$59.8M $19.12 147
2018 Q1 152M $2.35B -$1.01M $15.43 149
2017 Q4 153M $2.29B -$72.5M $14.99 162
2017 Q3 157M $2.48B +$150M $15.77 148
2017 Q2 147M $2.78B +$176M $18.88 163
2017 Q1 144M $2.46B +$320M $17.06 157
2016 Q4 140M $2.14B +$3.49M $15.29 157
2016 Q3 138M $2.19B +$20.6M $15.88 152
2016 Q2 135M $1.77B -$47.7M $13.07 141
2016 Q1 141M $1.54B +$5.47M $10.94 133
2015 Q4 140M $1.62B -$10M $11.59 132
2015 Q3 141M $1.47B -$31.6M $10.42 129
2015 Q2 144M $1.73B +$111M $12.06 137
2015 Q1 134M $2.14B +$7.94M $16.00 142
2014 Q4 133M $2.04B +$19.6M $15.32 128
2014 Q3 132M $1.71B +$65.6M $12.96 138
2014 Q2 126M $1.93B -$76.5M $15.33 141
2014 Q1 132M $1.62B +$224M $12.32 136